NOXXON Pharma develops and commercializes drug-based therapeutics for the treatment of cancer... Read more
NOXXON Pharma develops and commercializes drug-based therapeutics for the treatment of cancer... Read more
News
Jul 01, 2023
Gettotext
Noxxon Pharma: Noxxon Pharma becomes TME Pharma
Jul 15, 2022
MarketScreener
Noxxon Pharma: NOXXON Pharma N : Inside Information / Other news releases
Jul 13, 2022
Easy Tip
Noxxon Pharma: NOXXON PHARMA - HALF-YEARLY REPORT ON THE LIQUIDITY CONTRACT WITH INVEST SECURITIES
Jul 12, 2022
Easy Tip
Noxxon Pharma: NOXXON Publicizes Modifications to Its Supervisory Board
Jul 12, 2022
Easy Tip
Noxxon Pharma: NOXXON Declares High-Line Information of Section 1/2 GLORIA Research With NOX-A12 in Partially Resected or Biopsy-Solely MGMT-Unmethylated Newly-Identified Glioblastoma Sufferers
Jul 08, 2022
Easy Tip
Noxxon Pharma: Prime-Line Outcomes from NOXXON'S NOX-A12 Part 1/2 GLORIA Trial in Mind Most cancers to Be Introduced throughout 2022 ASCO Annual Assembly
Jul 07, 2022
MarketScreener
Noxxon Pharma: NOXXON Pharma N : Bryan Jennings
Jun 30, 2022
Easy Tip
Noxxon Pharma: NOXXON PROVIDES RESULTS OF ITS 2022 ANNUAL GENERAL MEETING OF SHAREHOLDERS
Jun 29, 2022
MarketScreener
Noxxon Pharma: NOXXON Pharma N : Download transcript
Jun 29, 2022
Easy Tip
Noxxon Pharma: Noxxon to Host Key Opinion Chief Webinar on GLORIA Examine Prime-line Outcomes of NOX-A12 & Radiotherapy Mixture in First-line Glioblastoma
Noxxon Pharma Competitors
1
2
3
4
5
6
7
8
9
10